AIIMS Delhi Advances Stroke Care with Successful Clinical Trial of Supernova Stent

AIIMS Delhi has advanced stroke care in India by conducting a dedicated clinical trial of a newbrainstent designed for severestrokepatients. The GRASSROOT trial tested the Supernova stent by Gravity Medical Technology and showed excellent safety and effectiveness, officials confirmed. Published in the Journal of Neurointerventional Surgery (JNIS), AIIMS Delhi served as the national coordinating centre and lead enrolling site for this trial of a next-generation stroke device. Dr Shailesh B Gaikwad, Professor and Head of the Department of Neuroimaging and Interventional Neuroradiology at AIIMS Delhi and National Principal Investigator of the GRASSROOT trial, called it a significant step for stroke treatment in India. The Supernova stent demonstrated strong results in clot removal and restoring blood flow in severe stroke patients. Data from the GRASSROOT trial were submitted to the Central Drugs Standard Control Organisation (CDSCO), after which the device received approval for routine use across India—based entirely on domestic clinical trial data. Conducted across eight centres, the trial also contributes to the Make-in-India initiative and strengthens India’s capabilities in advanced stroke care.